Initiator Pharma AS (OSTO:INIT) Cyclically Adjusted Book per Share: kr0.73 (As of Mar. 2026)


OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.65
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Cyclically Adjusted Book per Share?

Initiator Pharma AS OSTO:INIT -1.12% 24 Cyclically Adjusted Book per Share is kr0.73 as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Initiator Pharma AS's adjusted book value per share for the three months ended in Mar. 2026 was kr0.379. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.73 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-13), Initiator Pharma AS's current stock price is kr2.65. Initiator Pharma AS's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr0.73. Initiator Pharma AS's Cyclically Adjusted PB Ratio of today is 3.63.

During the past 10 years, the highest Cyclically Adjusted PB Ratio of Initiator Pharma AS was 3.63. The lowest was 0.00. And the median was 0.00.


Initiator Pharma AS  (OSTO:INIT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Initiator Pharma AS's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.65/0.73
=3.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PB Ratio of Initiator Pharma AS was 3.63. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Initiator Pharma AS Cyclically Adjusted Book per Share Related Terms


Initiator Pharma AS Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS Cyclically Adjusted Book per Share Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.73

OSTO:INIT vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Initiator Pharma AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Initiator Pharma AS Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Initiator Pharma AS's Cyclically Adjusted PB Ratio falls into.


OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Initiator Pharma AS's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.379/121.6800*121.6800
=0.379

Current CPI (Mar. 2026) = 121.6800.

Initiator Pharma AS Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 100.600 0.000
201609 0.000 100.200 0.000
201612 -0.043 100.300 -0.052
201703 1.470 101.200 1.767
201706 1.249 101.200 1.502
201709 0.953 101.800 1.139
201712 0.709 101.300 0.852
201803 0.387 101.700 0.463
201806 0.836 102.300 0.994
201809 0.584 102.400 0.694
201812 0.914 102.100 1.089
201903 0.850 102.900 1.005
201906 0.665 102.900 0.786
201909 0.572 102.900 0.676
201912 0.547 102.900 0.647
202003 0.425 103.300 0.501
202006 0.336 103.200 0.396
202009 0.386 103.500 0.454
202012 0.662 103.400 0.779
202103 0.579 104.300 0.675
202106 1.034 105.000 1.198
202109 1.241 105.800 1.427
202112 1.104 106.600 1.260
202203 0.628 109.900 0.695
202206 0.565 113.600 0.605
202209 1.025 116.400 1.071
202212 0.960 115.900 1.008
202303 0.712 117.300 0.739
202306 0.428 116.400 0.447
202309 0.294 117.400 0.305
202312 0.319 116.700 0.333
202403 0.642 118.400 0.660
202406 0.510 118.500 0.524
202409 0.428 118.900 0.438
202412 0.406 118.900 0.415
202503 0.317 120.200 0.321
202506 0.217 120.700 0.219
202509 0.699 121.600 0.699
202512 0.629 121.200 0.631
202603 0.379 121.680 0.379

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr0.73 mean?
Initiator Pharma AS (OSTO:INIT) has a Cyclically Adjusted Book per Share of kr0.73 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Initiator Pharma AS and its competitors.
Is Initiator Pharma AS's Cyclically Adjusted Book per Share too high?
Initiator Pharma AS's current Cyclically Adjusted Book per Share is kr0.73. Overall, Initiator Pharma AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Initiator Pharma AS's Cyclically Adjusted Book per Share of kr0.73 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current Cyclically Adjusted Book per Share is kr0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current Cyclically Adjusted Book per Share of kr0.73. The current Cyclically Adjusted Book per Share is kr0.73. Initiator Pharma AS's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current Cyclically Adjusted Book per Share is kr0.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.65
Price